Replies to post #24099 on RespireRx Pharmaceuticals Inc (RSPI)

[jerrydylan]

This had been rumored for years, not months.

[DewDiligence]

I think MRK is getting SGP at a good price, but there’s a hitch: SGP will lose its ex-US rights to Remicade if JNJ successfully challenges the MRK-SGP deal’s structure being a reverse merger in which SGP is the surviving legal entity. JNJ can argue that the reverse merger constitutes a kind of fraudulent conveyance to circumvent the Remicade change of control agreement.

[gfp927z]

Neuro, I also noticed that Rodman/Renshaw's market cap now appears to be down around Cortex's level. I wonder if R+R is still a major player in arranging bio financings, or are they being supplanted by other sources of private equity?

[enemem]

Which prospective partners are still viable in the very short time-frame cor is limited to (barring a PIPE)?